# Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.

> **NCT03921216** · — · SUSPENDED · sponsor: **Karolinska University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Chronic Kidney Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03921216
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-04-17
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Covid19
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03921216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03921216, "Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03921216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*